Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity

Introduction: Sodium arsenite (SA), NaAsO2, is among the most hazardous toxicants, and wide use and presence of this toxicant leads to a severe environmental threat. Exposure to SA is associated with many health concerns, such as the prevalence of cancer and diabetes mellitus type 2 (DMT2). Many stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Ramtin Farhadi, Marzieh Daniali, Maryam Baeeri, Reza Khorasani, Hamed Haghi-Aminjan, Mahdi Gholami, Mahban Rahimifard, Mona Navaei-Nigjeh, Mohammad Abdollahi
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025004931
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586279622017024
author Ramtin Farhadi
Marzieh Daniali
Maryam Baeeri
Reza Khorasani
Hamed Haghi-Aminjan
Mahdi Gholami
Mahban Rahimifard
Mona Navaei-Nigjeh
Mohammad Abdollahi
author_facet Ramtin Farhadi
Marzieh Daniali
Maryam Baeeri
Reza Khorasani
Hamed Haghi-Aminjan
Mahdi Gholami
Mahban Rahimifard
Mona Navaei-Nigjeh
Mohammad Abdollahi
author_sort Ramtin Farhadi
collection DOAJ
description Introduction: Sodium arsenite (SA), NaAsO2, is among the most hazardous toxicants, and wide use and presence of this toxicant leads to a severe environmental threat. Exposure to SA is associated with many health concerns, such as the prevalence of cancer and diabetes mellitus type 2 (DMT2). Many studies suggest that SA induces inflammation and biochemical impairments through different mechanisms, including increasing oxidative stress and altering vital genes such as biochemical and anti-inflammatory. Recent studies on melatonin (MLT), a harmless hormone secreted in the body generally for induction of sleepiness, find many beneficial and positive effects. Mitigating different harms and toxicities through different mechanisms, such as antioxidant properties, anti-inflammatory effects, and critical gene regulation, is essential. Due to these findings, this study aimed to evaluate the hypothesis that MLT may ameliorate pancreatic damage caused by exposure to SA. Methods: Forty-eight adult healthy male wistar rats aged 7–8 weeks were divided into eight for this research. Group 1 did not receive any intervention. Group 2 received 10 mg/kg/day MLT through intraperitoneal (IP) injection. Groups 3, 4, and 5 received 1.5 (1/10 LD50), 5 (1/3 LD50), and 7.5 (1/2 LD50) mg/kg SA, respectively. Groups 6, 7, and 8 were given 1.5 (1/10 LD50), 5 (1/3 LD50), and 7.5 (1/2 LD50) mg/kg of SA along with 10 mg/kg/day MLT, respectively, during the last ten days of the experiment. After 28 days of the experiment, the blood and tissue samples of the pancreas were removed for biochemical and pathological examination. Results: MLT attenuates SA toxicity by reducing oxidative stress biomarkers and inflammation markers. Moreover, MLT improves SA exposure's biochemical and functional damages by regulating related genes and pathways. Conclusion: MLT poses protective and preventive effects on the pancreas against exposure to SA. However, MLT's therapeutic and beneficial impacts have great potential for further investigation.
format Article
id doaj-art-91c85673b5dd4d1a8f18ec5719bfd9de
institution Kabale University
issn 2405-8440
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-91c85673b5dd4d1a8f18ec5719bfd9de2025-01-26T05:04:16ZengElsevierHeliyon2405-84402025-02-01113e42113Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicityRamtin Farhadi0Marzieh Daniali1Maryam Baeeri2Reza Khorasani3Hamed Haghi-Aminjan4Mahdi Gholami5Mahban Rahimifard6Mona Navaei-Nigjeh7Mohammad Abdollahi8Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, IranDepartment of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, IranDepartment of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran; Corresponding author. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran.Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, IranDepartment of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, IranDepartment of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, IranDepartment of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, IranDepartment of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, IranDepartment of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran; Toxicology and Diseases Specialty Group, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran; Corresponding author. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran.Introduction: Sodium arsenite (SA), NaAsO2, is among the most hazardous toxicants, and wide use and presence of this toxicant leads to a severe environmental threat. Exposure to SA is associated with many health concerns, such as the prevalence of cancer and diabetes mellitus type 2 (DMT2). Many studies suggest that SA induces inflammation and biochemical impairments through different mechanisms, including increasing oxidative stress and altering vital genes such as biochemical and anti-inflammatory. Recent studies on melatonin (MLT), a harmless hormone secreted in the body generally for induction of sleepiness, find many beneficial and positive effects. Mitigating different harms and toxicities through different mechanisms, such as antioxidant properties, anti-inflammatory effects, and critical gene regulation, is essential. Due to these findings, this study aimed to evaluate the hypothesis that MLT may ameliorate pancreatic damage caused by exposure to SA. Methods: Forty-eight adult healthy male wistar rats aged 7–8 weeks were divided into eight for this research. Group 1 did not receive any intervention. Group 2 received 10 mg/kg/day MLT through intraperitoneal (IP) injection. Groups 3, 4, and 5 received 1.5 (1/10 LD50), 5 (1/3 LD50), and 7.5 (1/2 LD50) mg/kg SA, respectively. Groups 6, 7, and 8 were given 1.5 (1/10 LD50), 5 (1/3 LD50), and 7.5 (1/2 LD50) mg/kg of SA along with 10 mg/kg/day MLT, respectively, during the last ten days of the experiment. After 28 days of the experiment, the blood and tissue samples of the pancreas were removed for biochemical and pathological examination. Results: MLT attenuates SA toxicity by reducing oxidative stress biomarkers and inflammation markers. Moreover, MLT improves SA exposure's biochemical and functional damages by regulating related genes and pathways. Conclusion: MLT poses protective and preventive effects on the pancreas against exposure to SA. However, MLT's therapeutic and beneficial impacts have great potential for further investigation.http://www.sciencedirect.com/science/article/pii/S2405844025004931Sodium arseniteMelatoninOxidative stressInflammationDiabetes
spellingShingle Ramtin Farhadi
Marzieh Daniali
Maryam Baeeri
Reza Khorasani
Hamed Haghi-Aminjan
Mahdi Gholami
Mahban Rahimifard
Mona Navaei-Nigjeh
Mohammad Abdollahi
Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity
Heliyon
Sodium arsenite
Melatonin
Oxidative stress
Inflammation
Diabetes
title Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity
title_full Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity
title_fullStr Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity
title_full_unstemmed Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity
title_short Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity
title_sort molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity
topic Sodium arsenite
Melatonin
Oxidative stress
Inflammation
Diabetes
url http://www.sciencedirect.com/science/article/pii/S2405844025004931
work_keys_str_mv AT ramtinfarhadi molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT marziehdaniali molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT maryambaeeri molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT rezakhorasani molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT hamedhaghiaminjan molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT mahdigholami molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT mahbanrahimifard molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT monanavaeinigjeh molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity
AT mohammadabdollahi molecularevidenceoftheinhibitorypotentialofmelatoninagainstsodiumarsenitetoxicity